Increased Mortality in Chronic Kidney Disease: A Call to Action

@article{Perazella2006IncreasedMI,
  title={Increased Mortality in Chronic Kidney Disease: A Call to Action},
  author={Mark A Perazella and Samina S. Khan},
  journal={The American Journal of the Medical Sciences},
  year={2006},
  volume={331},
  pages={150-153}
}
The mortality rate among patients with chronic kidney disease is much higher than among those without. As glomerular filtration rate declines and patients approach end-stage renal disease, the mortality rate increases and patients at this stage are more likely to die than receive renal replacement therapy. The higher mortality and its underlying causes among chronic kidney disease patients is a serious issue. Lack of physician awareness of chronic kidney disease and its association with excess… Expand
Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease
TLDR
Generally, in CKD patients with IHD an aggressive approach to IHD is warranted, a low threshold for diagnostic testing should be employed, and awaiting a clinical trial targeting these patients they should be considered for all proven strategies to improve outcomes. Expand
Do patients with chronic kidney disease get optimal cardiovascular risk reduction?
TLDR
The pathogenesis of cardiovascular disease in CKD differs subtly from that of non-CKD patients, and hypertension, hypercholesterolaemia and smoking cessation management should be optimized and may require multiple agents and approaches, particularly as CKD advances. Expand
Chronic kidney disease: implications for the perioperative period.
TLDR
Renal dysfunction as a predictor of perioperative outcomes is discussed together with therapeutic interventions aimed at the protection of renal function and better interventions and diagnostic tools are needed to further improve peri operative morbidity and mortality in patients with CKD. Expand
Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study.
TLDR
Estimated GFR appears to discriminate prognosis between patients with established cardiovascular disease and reduced estimated glomerular filtration rate, a significant risk factor for morbidity and mortality in patients with cardiovascular disease in the community. Expand
C URRENT OPINION Do patients with chronic kidney disease get optimal cardiovascular risk reduction
TLDR
The pathogenesis of cardiovascular disease in CKD differs subtly from that of non-CKD patients, and hypertension, hypercholesterolaemia and smoking cessation management should be optimized and may require multiple agents and approaches, particularly as CKD advances. Expand
AYURVEDIC MANAGEMENT OF CHRONIC KIDNEY DISEASE: A CASE STUDY
In recent years, chronic kidney disease (CKD) has received increasing attention owing to its enhancing rate of prevalence. Patients with CKD are at increased risk for cardiovascular morbidity andExpand
The Frequency of Pulmonary Hypertension among End Stage Renal Disease Patients on Hemodialysis
This article may be cited as: Mirza I, Khan ZA, Baleegh M, Amirullah, Rahid T, Khan UZ. The frequency of pulmonary hypertension among end stage renal disease patients on hemodialysis. J Saidu MedExpand
Patients with chronic kidney disease.
TLDR
This article reviews patient risk stratification, preoperative evaluation and management, and perioperative interventions for renal protection in chronic kidney disease patients. Expand
Influence of chronic kidney disease on the outcome of patients with chronic total occlusion.
TLDR
KD attenuated the benefit from revascularization for CTO and was associated with a lower cumulative MACCE-free survival rate among patients, whether with or without CKD, while CABG was not superior to PCI among CTO patients, but with a reduction in MACCE in patientsWithout CKD. Expand
Original Article Influence of chronic kidney disease on the outcome of patients with chronic total occlusion
TLDR
CKD attenuated the benefit from revascularization for CTO, and CABG was not superior to PCI among CTO patients, but with a reduction in MACCE in patients without CKD. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 16 REFERENCES
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.
TLDR
The data suggest that efforts to reduce mortality in this population should be focused on treatment and prevention of coronary artery disease, congestive heart failure, diabetes mellitus, and anemia. Expand
Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors
TLDR
Traditional cardiovascular risk factors had larger associations with cardiovascular mortality than novel risk factors in elderly persons with chronic kidney disease. Expand
Chronic kidney disease and cardiovascular disease in the Medicare population.
TLDR
Diabetes, the leading cause of ESRD, is increasing in the general Medicare population at 4.4% per year, and cardiovascular disease is common, progresses at twice the rate, is associated with death before E SRD, and patients receive suboptimal risk factor monitoring. Expand
Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.
TLDR
Traditional cardiovascular risk factors had larger associations with cardiovascular mortality than novel risk factors in elderly persons with chronic kidney disease. Expand
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
TLDR
An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population and highlights the clinical and public health importance of chronic renal insufficiency. Expand
Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population.
TLDR
Elderly CHF patients are at high risk of death; this risk is magnified in the presence of CKD and anemia. Expand
Chronic kidney disease as cause of cardiovascular morbidity and mortality.
TLDR
It is concluded that there is an undeniable link between kidney dysfunction and cardiovascular risk and that the presence of even subtle kidney dysfunction should be considered as one of the conditions necessitating intensive prevention of this cardiovascular risk. Expand
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
TLDR
On a relative basis, patients with CKD were at a much greater risk for the least frequent study outcome, renal replacement therapy, than on an absolute basis, however, the high death rates of patientsWith CKD may reflect accelerated rates of atherosclerotic vascular disease and congestive heart failure. Expand
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.
TLDR
CKD is a risk factor for the composite outcome of all-cause mortality and cardiovascular disease in the general population and a more pronounced risk factor in blacks than in whites and it is hypothesized that this effect may be due to more frequent or more severe subclinical vascular disease secondary to hypertension or diabetes in black individuals. Expand
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
TLDR
This is the first study to show a greater PWV in patients with more advanced CKD from stages 1 to 5, and estimated GFR per 1.73 m2 and systolic BP were the major clinical determinants of arterial stiffness in Patients with CKD independent of conventional risk factors for CVD. Expand
...
1
2
...